• Dry Cracked Skin
  • Impetigo
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Surgery
  • Melasma
  • NP and PA
  • Anti-Aging
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Inflamed Skin

Another notch for imiquimod?

Article

New Orleans - Topical imiquimod (Aldara) treatment may play a role in preventing UVB-induced cutaneous immunosuppression, Anthony A. Gaspari, M.D., said at the annual meeting of the American Academy of Dermatology.

Related Videos
Related Content
The Weekly Roundup: November 26-December 1

The Weekly Roundup: November 26-December 1

Article
The Cutaneous Connection: Pearls for Atopic Dermatitis in College-Aged Patients

The Cutaneous Connection: Pearls for Atopic Dermatitis in College-Aged Patients

Podcast
Reviewing Dermatologic Manifestations of HIV Infection and Acquired Immunodeficiency Syndrome

Reviewing Dermatologic Manifestations of HIV Infection and Acquired Immunodeficiency Syndrome

Article
The Cutaneous Connection: Understanding Age-Approved Therapies in the Atopic Dermatitis Armamentarium

The Cutaneous Connection: Understanding Age-Approved Therapies in the Atopic Dermatitis Armamentarium

Podcast
Dual-Wavelength Laser Technology Demonstrates Promise in Atrophic Acne Scar Management

Dual-Wavelength Laser Technology Demonstrates Promise in Atrophic Acne Scar Management

Article
Samsung Bioepis Receives US License Date for Proposed Ustekinumab Biosimilar, SB17

Samsung Bioepis Receives US License Date for Proposed Ustekinumab Biosimilar, SB17

Article
© 2023 MJH Life Sciences

All rights reserved.